RxDoctor Payments Data

Elizabeth Spencer, MD

Vascular & Interventional Radiology · Highlands Ranch, CONPI 1740279504

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $149,925 of the $189,459 with a category attached, or 79.1%. Philips North America LLC accounts for 63.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $98,144 and has fallen 90.5% since, to $9,315 in 2025. Among vascular & interventional radiology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$189,459in general payments, 2019–2025

Across 247 payments — averaging $767.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$120K
  • Boston Scientific$38K
  • Medtronic$9K
  • Pfizer$9K
  • Bard Peripheral Vascular, Inc.$5K
  • E.r. Squibb & Sons, L.L.C.$3K
  • plus $5K from 14 others
$52,234in research payments, 2019–2025

Across 3 payments — averaging $17,411 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$28K
  • Medtronic$24K
  • Veniti, Inc.$250

What the payments were for

  • Consulting fees$24,82513%
  • Speaking & faculty fees$149,92579%
  • Travel & lodging$3,8722%
  • Food & beverage$8,3154%
  • Education$1,3221%
  • Other$1,2001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$189,459 in reported general payments places this provider in the 90th percentile of 105 vascular & interventional radiology providers in Colorado.

See all vascular & interventional radiology providers in Colorado

Medicare billing

Part B allowed, 2024
$212,948
Medicare patients
135
Services billed
752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl12$19

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Highlands Ranch

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →